Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
25.30Prev. Close
24.71Volume
171Total traded value
0.00 CrUpper Circuit
29.65Lower Circuit
19.77Fundamentals
| Market Cap | ₹11Cr |
| ROE | 23.59% |
| P/E Ratio(TTM) | 10.79 |
| EPS(TTM) | 2.29 |
| P/B Ratio | 2.55 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.32 |
| Book Value | 9.70 |
| Debt to Equity | 0.00 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Unjha Formulations
Unjha Formulations is a pharmaceutical company that manufactures Ayurvedic and Isabgol-based healthcare products, including contract manufacturing for well-known brands like Fybogel. The company focuses on providing affordable healthcare solutions that address real needs, guided by a customer-centric approach to fuel its growth and market presence. The company demonstrated strong financial performance by increasing its profit after tax by a significant 46% in the last fiscal year.;
| Parent Organisation | Unjha Formulations Limited |
| BSE Symbol | 531762 |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 58.80 | ||
| Ajanta Pharma | NA (0.00%) | 33.44 | ||
| Gland Pharma | NA (0.00%) | 36.89 | ||
| Eris Lifesciences | NA (0.00%) | 47.39 |